In addition to the listing of Poland and Slovenia, the EMA has revised the Q&A on the MRA. It informs inter alia about which products are included or not in the scope of the MRA. Furthermore, it clarifies questions regarding combination products or the necessity of import re-testing. By the way: this control must still be carried out until all European member states have been approved by the FDA.
More detailed information on the MRA can be found here.
EMA: Press Release
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.